A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancer

Strickler, John H.; Rushing, Christel N.; Niedzwiecki, Donna; McLeod, Abigail; Altomare, Ivy; Uronis, Hope E.; Hsu, S. David; Zafar, S. Yousuf; Morse, Michael A.; Chang, David Z.; Wells, James L.; Blackwell, Kimberly L.; Marcom, P. Kelly; Arrowood, Christy; Bolch, Emily; Haley, Sherri; Rangwala, Fatima A.; Hatch, Ace J.; Nixon, Andrew B.; Hurwitz, Herbert I.

doi:10.1186/s12885-019-6234-8

BMC Cancer

Article metrics
Last updated: Wed, 24 Apr 2024 3:58:29 Z

A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancer

Access & Citations

2038

Article Accesses
8

Web of Science
8

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com